Positive airway pressure

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Retrieved on: 
Wednesday, January 17, 2024
Ageing, Patient, Research, Dronabinol, PAP, Obstructive sleep apnea, Continuous positive airway pressure, AHI, API, Risk, Positive airway pressure, IRB, Acetazolamide, CPAP, Food, OSA, Safety, Institutional review board, Pharmaceutical industry

IRB approval of the protocol is a key step in activation of clinical trial sites for the RePOSA study.

Key Points: 
  • IRB approval of the protocol is a key step in activation of clinical trial sites for the RePOSA study.
  • The approval process involves review of the research protocol, informed consent procedures, recruitment materials, and participant risk versus benefit analysis.
  • The study is designed to facilitate a seamless transition between Phase 2 and Phase 3, reducing downtime and accelerating development timelines.
  • IRB approval of the protocol allows the U.S.-based sites to proceed with site-specific approval, which is a critical step in site activation.

Sleep Apnea Diagnostic Devices Market Report 2022: Technological Developments in Devices to Offer More Comfort Driving Adoption - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 10, 2022
Health, Medical Supplies, Medical Devices, Customer support, User (computing), Research, Decision-making, ASV, Business Growth Fund, Economic development, PSG, Clifton Springs Hospital & Clinic, Positive airway pressure, Acquisition, COVID-19, CAGR, Market share, Use, Strategic management, Value, Market share analysis, Growth, PAP, Nurse Next Door Home Healthcare Services, Medical device, Medicine, Retail, Polysomnography, Adult

The "Sleep Apnea Diagnostic Devices Market Research Report by Product, Therapeutic Devices, Patient Demographics, End-User, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sleep Apnea Diagnostic Devices Market Research Report by Product, Therapeutic Devices, Patient Demographics, End-User, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The Global Sleep Apnea Diagnostic Devices Market is projected to grow with a significant CAGR in the forecast period.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Sleep Apnea Diagnostic Devices Market.
  • Based on Therapeutic Devices, the market was studied across Adaptive Servo Ventilation (ASV) Devices Masks & Accessories, Oral Appliances, Oxygen Devices, and Positive Airway Pressure (PAP) Devices.

Cathay Capital Announces Strategic Investment in CPAP.com

Retrieved on: 
Wednesday, January 12, 2022
Entrepreneurship, Patient, Partner, Population, Ageing, Growth, Sleep, CEO, Obstructive sleep apnea, PAP, Leadership, Movement, Sleep apnea, Obesity, DTC, Company, COVID-19, TM Capital Corp., Positive airway pressure, CPAP, Board, Investment, Awareness, Management, Airline, Cathay

NEW YORK, Jan. 12, 2022 /PRNewswire/ --Investment firm Cathay Capital announced today it has made a strategic investment in CPAP.com .

Key Points: 
  • NEW YORK, Jan. 12, 2022 /PRNewswire/ --Investment firm Cathay Capital announced today it has made a strategic investment in CPAP.com .
  • Andre Puong, Partner of Cathay Capital said, "CPAP.com has been an innovator in the OSA space with an impressive and sustained growth trajectory since its founding.
  • Johnny Goodman, Co-Founder and CEO of CPAP.com said, "We're honored to partner with the entire Cathay Capital team to guide us in driving the next phase of our growth.
  • Cathay Capital Group is a global investment firm supporting companies at all stages throughout North America, Asia, Europe and Africa.

Global Positive Airway Pressure Devices Market Research Report (2021 to 2026) - by Product Type and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 7, 2021
Medical Devices, Health, Customer support, USD, Decision-making, CAGR, COVID-19, R, Business Growth Fund, Use, Growth, Compound annual growth rate, Investment, Certification, Positive airway pressure, Market share analysis, Acquisition, Strategic management, Technology, Value, Retail, Airline

What is the market size and forecast of the Global Positive Airway Pressure Devices Market?

Key Points: 
  • What is the market size and forecast of the Global Positive Airway Pressure Devices Market?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Positive Airway Pressure Devices Market?
  • What is the market share of the leading vendors in the Global Positive Airway Pressure Devices Market?
  • What modes and strategic moves are considered suitable for entering the Global Positive Airway Pressure Devices Market?

Ontario Home Respiratory Services Association Calling on Government to Change Planned Cuts to Funding for Respiratory Devices During Pandemic

Retrieved on: 
Thursday, August 26, 2021
Government, OMA, Gold, Ontario Medical Association, Access, PAP, GLOBE, Travel, Ministry of Health (Ontario), Small business, Ministry, Government of Ontario, Positive airway pressure, Ford Motor Company, Sleep, Patient, Atmosphere of Earth, Association, COVID-19, Medicine, Pharmaceutical industry

Current and future patients can expect an average increase of $400-$600 in costs for PAP devices, making the therapy and necessary support unaffordable for many Ontarians.

Key Points: 
  • Current and future patients can expect an average increase of $400-$600 in costs for PAP devices, making the therapy and necessary support unaffordable for many Ontarians.
  • As a result, many will become unprofitable or be forced to change business models to compensate for lost funding and coverage for patients.
  • OHRSA has recommended alternative options to funding cuts that would still reduce government expenditures and sustain vendors.
  • The Ontario Home Respiratory Services Association represents the collective interests of 25 member firms in the home respiratory industry, which represent the vast majority of all service locations operating in Ontario.

Global Sleep Apnea Devices Market (2020 to 2027) - Key Drivers and Challenges - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 11, 2021
Medical Devices, Health, People, Adoption, PSG, Hospital, American Academy, Sleep apnea, Positive airway pressure, European Respiratory Journal, OSA, Diabetes, Incidence, Sleep, Analysis, Patient, Diagnosis, American Academy of Sleep Medicine, Continuous positive airway pressure, CAGR, European Respiratory Society, Hypertension, Polysomnography, Brain, Degenerative disease, COVID-19, Prevalence, US, PAP, SCSI Peripheral Device Type, CPAP, Awareness, Government, Home care in the United States, Obstructive sleep apnea, Growth, Obesity, Chest (journal), Pharmaceutical industry, Health insurance

As per the Analysis, the Sleep Apnea Devices Market was valued at US$ 5.2 Billion in 2020.It is likely that the Sleep Apnea Machines Market is expected to expand at a CAGR of 7.63% from 2020 - 2027.

Key Points: 
  • As per the Analysis, the Sleep Apnea Devices Market was valued at US$ 5.2 Billion in 2020.It is likely that the Sleep Apnea Machines Market is expected to expand at a CAGR of 7.63% from 2020 - 2027.
  • Further, to combat the condition named sleep apnea, the market has introduced equipment for managing sleeping apnea that facilitates breathing in patients suffering from sleep disorders.
  • In terms of device type, the global Sleep Apnea market is segmented into therapeutic devices and diagnostic devices.
  • In the therapeutic device segment, Positive Airway Pressure (PAP) devices are the most common devices used to treat sleep apnea.

Advisory - Philips Respironics recalls several models of CPAP and BiLevel PAP machines and mechanical ventilators

Retrieved on: 
Friday, July 30, 2021
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Medical equipment, Intensive care medicine, Respiratory therapy, Positive airway pressure, Respironics, Ventilator, Philips, Continuous positive airway pressure

Products:Philips Respironics Continuous Positive Airway Pressure (CPAP) machines, BiLevel Positive Airway Pressure (BiLevel PAP) machines and mechanical ventilators

Key Points: 
  • Products:Philips Respironics Continuous Positive Airway Pressure (CPAP) machines, BiLevel Positive Airway Pressure (BiLevel PAP) machines and mechanical ventilators
    Issue:Philips Respironics is recalling several models because of reports of the sound-reducing foam breaking down, which could pose potential health risks.
  • Philips has established a registration process where you can look up your device serial number and begin a claim if your unit is affected.
  • Philips Respironics (Philips) has recalled several models of its Continuous Positive Airway Pressure (CPAP) machines, BiLevel Positive Airway Pressure (BiLevel PAP) machines and mechanical ventilators in Canada and internationally.
  • Preliminary laboratory analysis by Philips determined that extreme operating temperatures and ozone cleaning methods may increase the breakdown of the foam.

Positive Airway Pressure Devices Global Market Report 2021: COVID-19 Growth, Impacts and Changes - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021
Health, General Health, Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Intensive care medicine, Medical equipment, Respiratory therapy, Modes of mechanical ventilation, Positive airway pressure, Continuous positive airway pressure, Non-invasive ventilation, Continuous spontaneous ventilation

Positive Airway Pressure Devices Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global positive airway pressure devices market.

Key Points: 
  • Positive Airway Pressure Devices Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global positive airway pressure devices market.
  • The positive airway pressure devices market consists of sales of positive airway pressure devices by entities (organizations, sole traders, and partnerships) that manufacture positive airway pressure (PAP) devices that are used to trap air under pressure into the airway of the lungs.
  • The main types of positive airway pressure devices are continuous positive airway pressure (CPAP), auto-titrating positive airway pressure (APAP), and bilevel positive airway pressure (BiPAP).
  • Potable positive airway pressure devices is a growing trend in the positive airway pressure devices market.

Global Respiratory Care Devices Markets, 2015-2020 & 2021-2026: Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021
Medical devices, Health, Medicine, Health care, Clinical medicine, Respiratory therapy, Medical equipment, Dosage forms, Intensive care medicine, Mechanical ventilation, Nebulizer, Positive airway pressure, Humidifier, Respiratory therapist

The global respiratory care devices market exhibited strong growth during 2015-2020.

Key Points: 
  • The global respiratory care devices market exhibited strong growth during 2015-2020.
  • Looking forward, the global respiratory care devices market to grow at a CAGR of around 11% during the forecast period (2021-2026).
  • Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices.
  • What is the structure of the global respiratory care devices industry and who are the key players?

Introducing the Portex® Acapella® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

Retrieved on: 
Wednesday, April 28, 2021
Health, Medical devices, Cardiology, Medicine, Clinical medicine, Medical specialties, Chronic lower respiratory diseases, Mechanical ventilation, Intensive care medicine, Respiratory therapy, Medical equipment, Acute exacerbation of chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease, Positive airway pressure, Bronchitis

b'Smiths Medical, a leading medical device manufacturer, today announces the launch of the acapella\xc2\xae choice blue vibratory PEP therapy system.

Key Points: 
  • b'Smiths Medical, a leading medical device manufacturer, today announces the launch of the acapella\xc2\xae choice blue vibratory PEP therapy system.
  • Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika\xc2\xae and Acapella\xc2\xae Devices.
  • Positive Expiratory Pressure Therapy with And Without Oscillation and Hospital Length of Stay for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
  • 2019 Nov 20;14:2553-2561.\nMesquita FO, Galindo-Filho VC, Neto JL, Galv\xc3\xa3o AM, Brand\xc3\xa3o SC, Fink JB, Dornelas-de-Andrade A. Scintigraphic assessment of radio-aerosol pulmonary deposition with the acapella positive expiratory pressure device and various nebulizer configurations.